The number of adolescents who completed the human papillomavirus (HPV) vaccine series increased five percentage points from 2016 to 2017, according to the CDC’s Morbidity and Mortality Weekly Report. About 66 percent of kids 13 to 17 received the first dose of the HPV vaccine and almost 49 percent received all the recommended doses in 2017. HPV infection increases the risk for certain types of cancer, including cervical cancer and cancer of the throat.
Although HPV vaccination rates are improving, about 51 percent of adolescents haven’t completed the series, according to the CDC. Eleven percent fewer teens in rural areas of the United States have received the first dose of the HPV vaccine than those in urban areas.
Because of the interval between HPV infection and the development of cancers related to the virus, it will take decades before the benefits of vaccination are fully known, but experts predict that HPV vaccination could prevent 90 percent (about 31,200 cases yearly) of cancers caused by the virus in the U.S.
Sourced from: CDC